This innovative antibody-conjugated liposome system specifically targets the cell cycle regulator CCNA2, allowing for more effective and localized delivery of therapeutic agents directly to melanoma cells. By focusing on this critical regulator, the treatment not only enhances the therapeutic efficacy but also minimizes the adverse side effects commonly associated with systemic drug administration. Recent research suggests that this targeted approach holds significant promise in inhibiting tumor growth, potentially leading to improved outcomes for patients suffering from melanoma.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2072MZ | Mouse Anti-CCNA2 Recombinant Antibody (clone 3223D3b) | WB | Mouse IgG1 |
MRO-0408-CN | Mouse Anti-CCNA2 Recombinant Antibody (clone N0-E3) | WB, IF, IHC | Mouse IgG1 |
MRO-0409-CN | Rabbit Anti-CCNA2 Recombinant Antibody (clone CBACN-161) | WB, IF, IHC | Rabbit IgG |
VS3-FY210 | Recombinant Rabbit Anti-CCNA2 Antibody (clone R02-3H6) | WB, IHC-F, IHC-P, ICC, IF, IP | Rabbit IgG |
VS3-FY211 | Recombinant Rabbit Anti-CCNA2 Antibody (clone R02-9B6) | WB, IHC-F, IHC-P, ICC, IF, IP | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY166. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.